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Abstract
Background: Overvaluation of shape and weight is a key diagnostic feature of anorexia nervosa (AN); however,
limited research has evaluated the clinical utility of differentiating between weight versus shape concerns. Understanding
differences in these constructs may have important implications for AN treatment given the focus on weight regain. This
study examined differences in treatment outcome between individuals whose primary concern was weight
versus those whose primary concern was shape in a randomized controlled trial of treatment for adolescent AN.
Methods: Data were drawn from a two-site randomized controlled trial that compared family-based treatment
and adolescent focused therapy for AN. Chi-square tests and logistic regression analyses were conducted.
Results: Thirty percent of participants presented with primary weight concern (n = 36; defined as endorsing higher
Eating Disorder Examination (EDE) Weight Concern than Shape Concern subscale scores); 60 % presented with primary
shape concern (n = 72; defined as endorsing higher EDE Shape Concern than Weight Concern scores). There were no
significant differences between the two groups in remission status at the end of treatment. Treatment did not
moderate the effect of group status on achieving remission.
Conclusions: Results suggest that treatment outcomes are comparable between adolescents who enter treatment for
AN with greater weight concerns and those who enter treatment with greater shape concerns. Therefore, treatment
need not be adjusted based on primary weight or primary shape concerns.
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Background
A key diagnostic feature of anorexia nervosa (AN) is an
overvaluation of shape and weight [1, 2], with patients
tending to evaluate their self-worth in terms of their shape
and weight. The Diagnostic and Statistical Manual for
Mental Disorders (DSM-5) includes the third diagnostic
criterion for AN as “disturbance in the way in which
one’s body weight or shape is experienced, undue influ-
ence of body weight or shape on self-evaluation, or de-
nial of the seriousness of the current low body weight”
[2]. The gold-standard interview assessment of eating
disorder pathology, the Eating Disorder Examination
(EDE), includes ‘shape concern’ and ‘weight concern’ as
two separate subscales [3]. With the exception of one
overlapping question, the weight concern subscale and
the shape concern subscale on the EDE are comprised
of different questions, suggesting the assessment con-
ceptualizes shape and weight concerns as different con-
structs with distinct latent psychopathology and of
separate clinical importance.
Despite the hypothesized clinical importance of distin-
guishing weight from shape, many factor analytic studies
have demonstrated that weight and shape concerns may
not represent separate constructs. In fact, two compre-
hensive literature reviews have demonstrated that factor
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analyses have generally failed to discriminate between a
shape concern factor and weight concern factor on the
EDE and EDE-Questionnaire (EDE-Q; the self-report
questionnaire of the EDE), suggesting that separating
shape and weight concerns may not be a meaningful dis-
tinction for many people [4, 5]. However, the research
to-date has focused primarily on the validity of the EDE
and the EDE-Q as an assessment tool, but the clinical
utility of separating these constructs remains a gap in
the literature. Additionally, although the psychometric
properties of these assessment tools indicate that con-
cerns about weight and shape may overlap, neuroimag-
ing studies indicate that individuals with AN have a
neurobiologically distinct response to the estimation of
their own body shape [6]. Individuals with AN appear to
misperceive their own body shape as larger than the body
shape of healthy controls, and also perceive certain body
shapes as more desirable than others. These perceptions
are associated with unique regions of neural activation, in-
dicating that concerns about ‘shape’ itself are important to
patients with AN, and that these misperceptions occur re-
gardless of the actual body weight of the individual [7, 8].
It is necessary for eating disorder treatment research
to not only determine the overall efficacy of a particular
treatment, but to also identify factors that influence
treatment response [9]. Distinguishing predictors that
may be modifiable over the course of treatment is of
significant importance in successful treatment outcome
and the precise delivery of treatment services. Weight (i.e.,
the number on the scale) is highly relevant to the treat-
ment of both adolescents and adults with AN. Family-
based treatment (FBT), which is efficacious for treating
adolescents with AN [10], considers weight restoration
and re-feeding primary treatment targets, with little
discussion topics outside of weight progress in the be-
ginning sessions [11]. Additionally, cognitive-behavioral
therapy for AN also prioritizes weight regain during
treatment, including “weekly weighing” at every therapy
session [12].
Given the focus of weight as a treatment target for
patients with AN, it is possible that individuals who en-
dorse heightened valuation of their weight compared to
their shape may experience greater difficulty tolerating
weight gain, resulting in poorer treatment outcomes.
Moreover, given that early weight gain in treatment pre-
dicts better outcomes for adolescents with AN [13, 14],
understanding factors that may impact treatment en-
gagement and response may inform subpopulations for
whom treatment tailoring may be indicated. A better
understanding of the clinical importance of shape and
weight concerns in this population may help to improve
treatment efficacy.
Using data from a two-site randomized controlled trial
(RCT) of treatment for adolescents with AN, the purpose
of this study was to examine differences in treatment out-
come between individuals whose primary concern was
weight compared to those whose primary concern was
shape. Though reviews of the psychometric properties of
the EDE and EDE-Q show that data do not support a dis-
tinction between the weight concern and shape concern
subscales, the prognostic clinical value of evaluating these
as separate concepts has yet to be explored. To our know-
ledge, this is the first evaluation of weight concern and
shape concerns as separate constructs predicting treat-
ment outcome for individuals with AN. Additionally, to
our knowledge, this is the first evaluation examining the
predictive clinical utility of separating weight concern
items and shape concern items during the eating disorder
symptom assessment process. We hypothesized that ado-
lescents who endorsed heightened valuation of their
weight compared to their shape would experience greater




Data were drawn from a two-site RCT (Chicago and
Stanford) that compared family-based treatment (FBT)
and adolescent-focused therapy (AFT) [10]. Adolescents
(N = 121) meeting DSM-IV criteria for AN, excluding
the criterion requiring the absence of at least three men-
strual cycles, were randomly assigned to one of the two
treatments. Each treatment was delivered for a total of
24 h (twenty-four 1-h sessions for adolescents receiving
FBT, thirty-two 45-min sessions for adolescents receiv-
ing AFT) over 12 months. In-person study assessments
were conducted at baseline and end of treatment (EOT).
For the purposes of the current analyses, participants
considered having ‘primary weight concern’ (PWC; n =
36, 30 %) endorsed higher baseline EDE Weight Concern
subscale scores than Shape Concern subscale scores;
participants considered having ‘primary shape concern’
(PSC; n = 72, 60 %) endorsed higher baseline EDE Shape
Concern subscale scores than Weight Concern subscale
scores. Additionally, for the purposes of this study, par-
ticipants with equal weight and shape concern subscale
scores (n = 13, 10 %) were excluded from the analyses.
At end of treatment, normal weight was defined as ≥
95 % of expected body weight for sex, age, and height.
Treatment remission was defined as achieving both normal
weight and a global EDE score within 1 standard deviation
(SD) of published norms (1.59) [15, 16]. Full disclosure of
the purpose of the study, the benefits and risks to patients’
participation, and the confidential nature of information
obtained during the study is explained to participants
per ethics board requirements. The Institutional Review
Boards at both sites approved this study, and all adoles-
cents and at least one parent gave informed assent and
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consent, respectively. Further details of this the study




Weight in pounds was objectively measured by trained as-
sessors at baseline, at every treatment session, and at EOT.
At each study assessment, participants were weighed wear-
ing a hospital gown on a balance-beam scale that was
regularly recalibrated.
Eating Disorder Examination (EDE)
The EDE is a semi-structured interview used to assess
eating disorder pathology [17]. The EDE (version 12.0)
was administered at baseline and EOT. The EDE was
used to assess psychological and behavioral symptoms
of an eating disorder, yielding four subscales (Restraint,
Eating Concern, Shape Concern, Weight Concern) and a
global score, which indicates level of overall eating dis-
order pathology. Scores range from 0 to 6, with higher
scores indicating greater severity of eating disorder path-
ology. The EDE has demonstrated good reliability and val-
idity and has been utilized in many studies of youth with
eating disorders [5].
Analysis plan
Analyses were conducted using SPSS Version 22.0. Chi-
square tests were used to evaluate between-group dif-
ferences at baseline between PWC and PSC groups on
demographic variables and on treatment condition. Treat-
ment outcome at the end of treatment (i.e., achieving re-
mission or achieving normal weight) was compared by
PWC or PSC group using chi-square tests. Logistic regres-
sion was used to evaluate the interaction between PWC
versus PSC and treatment condition on the proportion
of participants achieving remission or achieving normal
weight at end of treatment. P-values less than 0.05 were
considered statistically significant.
Results
Participants were mostly females (89.8 %) with a mean
age of 14.47 years (SD = 1.6). Participants identified as
75 % non-Hispanic Whites (n = 81), 8.3 % Hispanic
White (n = 9), 11.1 % Asian (n = 12), and 5.6 % as Other
(n = 6). Mean percent expected body weight was 80.6 %
(SD = 3.58) using Centers for Disease Control and Pre-
vention growth charts. The average duration of illness
was 11.9 months (SD = 12.0). Mean difference in ‘shape
concern’ scores and ‘weight concern’ scores on the EDE
among participants was 0.89 (SD = 0.31). Adolescents
with PWC did not differ significantly from those with PSC
on age, gender, racial/ethnic minority status, duration of
illness (months), baseline percent expected body weight,
baseline EDE global score, treatment dropout status, or
prior hospitalization (ps > .165) (See Table 1).
No significant differences were found at baseline be-
tween the PWC and PSC groups by treatment condi-
tion (χ2 = 0.464, p = .496). There were no significant
differences between the two groups across treatments
in the proportion of participants achieving remission
(χ2 = 0.702, p = .482; PWC achieving remission n = 12,
33.3 %, PSC achieving remission n = 18, 30 %) or normal
weight (χ2 = 0.204, p = .659; PWC achieving normal weight
n = 13, 42 %, PSC achieving normal weight n = 23, 31.1 %).
The interaction between the effect of PWC/PSC group
status and treatment condition was not associated with
achieving remission (Exp(B) = 0.495, p = .457) or normal
weight (Exp(B) = 1.300, p = .775) post treatment.
A secondary analysis was conducted among partici-
pants with clinically-significant baseline weight and
shape pathology. Specifically, analyses were conducted
among the subset of participants (N = 26) with an EDE
score greater than or equal to 4 on either the weight
concern subscale (n = 5) or the shape concern subscale
(n = 21), given that a score of 4 on a subscale is considered
clinically significant [18, 19]. Mean difference in EDE
‘shape concern’ and ‘weight concern’ scores among this
subset was 1.14. There were no significant differences







Mean (SD) Mean (SD)
Age (in years) 14.17 (1.483) 14.62 (1.626) t (106) = 1.39 .165
Duration Ill (mo) 11.64 (9.04) 12.09 (13.28) t (106) = .184 .855
Percent EBW 80.91 (3.90) 80.43 (3.43) t (106) = −.646 .520
n (%) n (%)
Female 32 (90.2 %) 65 (88.9 %) χ2 (1) = 0.051 .532
White 26 (72.2 %) 55 (76.4 %) χ2 (1) = 0.431 .934
Prior Hospitalization 17 (47.2 %) 32 (44.4 %) χ2 (1) = 0.075 .472
Treatment Dropout 9 (25 %) 18 (25 %) χ2 (1) = 0.589 .745
Key: mo months, EBW Expected Body Weight
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between these two groups across treatments in the pro-
portion of participants achieving remission (χ2 = 1.250,
p = .264) or normal weight (χ2 = 1.544, p = .214).
Discussion
The current study was an exploratory analysis, examining
weight concern and shape concern as separate constructs
predicting remission from eating disorder treatment among
adolescents with AN. Given the importance of over-
valuation of shape and weight as a key clinical charac-
teristic of AN, it is of clinical significance to understand
the ways in which these concerns may separately influence
the outcome of treatment. Results of this study revealed
there were no differences in demographics, weight, or eat-
ing disorder pathology between adolescents who pre-
sented to treatment with primary weight concern versus
with primary shape concern, nor was there a significant
difference in clinical outcomes (i.e., remission, normal
weight) at the end of treatment. Further, the interaction
between treatment group did not moderate the effect of
primary weight versus shape concerns on achieving remis-
sion or normal weight at end of treatment. Thus, results
of this study suggest no significant differences between
the two constructs on predicting treatment results among
adolescents with AN and indicate that individuals with
higher weight concerns are as likely as those with higher
shape concerns to have good treatment outcome.
Results of the study were contrary to the hypothesis
that, given the focus on weight regain as a treatment tar-
get for AN, individuals who place a higher value on
weight than shape may have less successful treatment
outcomes. Although weight (i.e., the specific number on
the scale) restoration is often a primary treatment target
for adolescents with AN, it is possible that changes in
weight are quickly associated with changes in shape, re-
ducing the prognostic utility of these two constructs to
differentiate clinical outcomes by the end of treatment.
Further research to understand changes over the course
of treatment in weight concerns and shape concerns
may be beneficial for informing whether temporal differ-
ences impact treatment outcome.
Study results also contribute to the assessment litera-
ture on weight versus shape concerns regarding the
prognostic value of assessing these features as separate
constructs. Although the original validation study of the
EDE showed that the weight concern and shape concern
subscales could not be combined despite being closely
associated with one another [20], several factor analytic
studies have failed to differentiate between a shape con-
cern factor and weight concern factor on the EDE and
EDE-Q [5], which is consistent with our study findings.
Thus, results from the present study further inform as-
sessment issues by calling into question whether it is
clinically meaningful to assess shape concern and weight
concern as separate constructs in terms of its prognostic
value for AN treatment outcomes.
There are several limitations of the current study that
should be noted. First, this study defined primary
weight concern and primary shape concern as any dif-
ference between these two subscales, regardless of the
magnitude of this distinction, as the limited sample size
of adolescents in the study precluded setting a more
conservative distinction between the groups. Accord-
ingly, the mean difference of 0.89 (SD = 0.31) was small,
which may have limited the capacity to observe differ-
ences in outcome between these groups. However, this
also suggests that the mean difference between weight
and shape concern tends to be low, which is in keeping
with a unified weight and shape concern construct.
Additionally, the current study examined a treatment-
seeking sample of adolescents with AN, and thus study re-
sults may not generalize to other eating disorder samples.
Conclusions
Despite these limitations, this study represents the first
to examine whether weight concern and shape concern
differentially impact treatment outcome for adolescents
with AN. This study makes a clinical contribution in
understanding the influence that weight concern and
shape concern have as two separate components of AN,
and suggests that treatment outcomes are comparable
between adolescents who overvalue one or the other.
Further, it challenges the clinical relevance of assessing
weight concern and shape concern as separate constructs.
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